share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

辉瑞 | 4:持股变动声明-高管 JOHNSON RADY A
美股SEC公告 ·  08/02 11:39
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Executive Vice President Rady A. Johnson engaged in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Pfizer Inc. (PFE) Executive Vice President Rady A. Johnson engaged in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
2024年7月31日,辉瑞制药公司(PFE)执行副总裁Rady A. Johnson涉及了该公司的股票交易。公告中未披露交易的具体细节,如交易的股份数量、股份的性质、交易价格及股份的总价值。同时,该交易的动作类型和状态也未知。建议投资者寻求额外信息以充分了解该事件对其投资决策的影响。
2024年7月31日,辉瑞制药公司(PFE)执行副总裁Rady A. Johnson涉及了该公司的股票交易。公告中未披露交易的具体细节,如交易的股份数量、股份的性质、交易价格及股份的总价值。同时,该交易的动作类型和状态也未知。建议投资者寻求额外信息以充分了解该事件对其投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息